The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Srebp-controlled glucose metabolism is essential for NK cell functional responses
Open accessAbstract
Activated natural killer (NK) cells engage in a robust metabolic response that is required for normal effector function. Using genetic, pharmacological and metabolic analyses, we demonstrated an essential role for Srebp transcription factors in cytokine-induced metabolic reprogramming of NK cells that was independent of their conventional role in the control of lipid synthesis. Srebp was required for elevated glycolysis and oxidative phosphorylation and promoted a distinct metabolic pathway configuration in which glucose was metabolized to cytosolic citrate via the citrate-malate shuttle. Preventing the activation of Srebp or direct inhibition of the citrate-malate shuttle inhibited production of interferon-γ and NK cell cytotoxicity. Thus, Srebp controls glucose metabolism in NK cells, and this Srebp-dependent regulation is critical for NK cell effector function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More recently, it was demonstrated that the citrate–malate shuttle performs functions beyond that of an electron shuttle and, in fact, supports continuous citrate regeneration and TCA cycle intermediate homeostasis (119, 121).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [119]
Citations
Cites
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity
Cheng, S.-C., Quintin, J., Cramer, R. A., Shepardson, K. M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E. J., Martens, J. H. A., Rao, N. A., Aghajanirefah, A., et al. (2014) · Science · doi:10.1126/science.1250684 · Cited by 2,224
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,980
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
Huang, S. C., Everts, B., Ivanova, Y., O’Sullivan, D., Nascimento, M., Smith, A. M., Beatty, W. L., Love-Gregory, L. D., Lam, W. Y., O’Neill, C. M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2956 · Cited by 1,256
Targeting natural killer cells in cancer immunotherapy
Guillerey, C., Huntington, N. D., & Smyth, M. J. (2016) · Nature Immunology · doi:10.1038/ni.3518 · Cited by 1,081
Global burden of cancer attributable to high body-mass index in 2012: a population-based study
Arnold, M., Pandeya, N., Byrnes, G. B., Renehan, A. G., Stevens, G. A., Ezzati, M., Ferlay, J., Miranda, J. J., Romieu, I., Dikshit, R. P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71123-4 · Cited by 997
De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
Berod, L., Friedrich, C., Nandan, A., Freitag, J., Hagemann, S., Harmrolfs, K., Sandouk, A., Hesse, C., Castro, C. N., Bähre, H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3704 · Cited by 927
Cytokine-induced memory-like natural killer cells
Cooper, M. A., Elliott, J. M., Keyel, P. A., Yang, L., Carrero, J. A., & Yokoyama, W. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813192106 · Cited by 832
O’Sullivan, D., van der Windt, G. J. W., Huang, S. C.-C., Curtis, J. D., Chang, C.-H., Buck, M. D., Qiu, J., Smith, A. M., Lam, W. Y., DiPlato, L. M., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.005 · Cited by 790
Cytokine activation induces human memory-like NK cells
Romee, R., Schneider, S. E., Leong, J. W., Chase, J. M., Keppel, C. R., Sullivan, R. P., Cooper, M. A., & Fehniger, T. A. (2012) · Blood · doi:10.1182/blood-2012-04-419283 · Cited by 684
Shimano, H., Yahagi, N., Amemiya-Kudo, M., Hasty, A. H., Osuga, J.-I., Tamura, Y., Shionoiri, F., Iizuka, Y., Ohashi, K., Harada, K., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35832 · Cited by 607
Natural killer cell memory in infection, inflammation and cancer
Cerwenka, A., & Lanier, L. L. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2015.9 · Cited by 593
Radhakrishnan, A., Ikeda, Y., Kwon, H. J., Brown, M. S., & Goldstein, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700899104 · Cited by 556
Kidani, Y., Elsaesser, H., Hock, M. B., Vergnes, L., Williams, K. J., Argus, J. P., Marbois, B. N., Komisopoulou, E., Wilson, E. B., Osborne, T. F., et al. (2013) · Nature Immunology · doi:10.1038/ni.2570 · Cited by 552
mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
Donnelly, R. P., Loftus, R. M., Keating, S. E., Liou, K. T., Biron, C. A., Gardiner, C. M., & Finlay, D. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401558 · Cited by 509
Self-citationLimiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling
York, A. G., Williams, K. J., Argus, J. P., Zhou, Q. D., Brar, G., Vergnes, L., Gray, E. E., Zhen, A., Wu, N. C., Yamada, D. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.045 · Cited by 461
Immunometabolism: Cellular Metabolism Turns Immune Regulator
Loftus, R. M., & Finlay, D. K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.693903 · Cited by 460
Self-citation25-Hydroxycholesterol suppresses interleukin-1–driven inflammation downstream of type I interferon
Reboldi, A., Dang, E. V., McDonald, J. G., Liang, G., Russell, D. W., & Cyster, J. G. (2014) · Science · doi:10.1126/science.1254790 · Cited by 444
Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
Ni, J., Miller, M., Stojanovic, A., Garbi, N., & Cerwenka, A. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120944 · Cited by 434
Oliviero, B., Varchetta, S., Paudice, E., Michelone, G., Zaramella, M., Mavilio, D., Filippi, F. D., Bruno, S., & Mondelli, M. U. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.047 · Cited by 413
Amemiya-Kudo, M., Shimano, H., Hasty, A. H., Yahagi, N., Yoshikawa, T., Matsuzaka, T., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., et al. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m100417-jlr200 · Cited by 398
Im, S., Yousef, L., Blaschitz, C., Liu, J. Z., Edwards, R. A., Young, S. G., Raffatellu, M., & Osborne, T. F. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.001 · Cited by 368
Balmer, M. L., Ma, E. H., Bantug, G. R., Grählert, J., Pfister, S., Glatter, T., Jauch, A., Dimeloe, S., Slack, E., Dehio, P., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.016 · Cited by 361
Shimomura, I., Shimano, H., Korn, B. S., Bashmakov, Y., & Horton, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35299 · Cited by 333
Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells
Keating, S. E., Zaiatz-Bittencourt, V., Loftus, R. M., Keane, C., Brennan, K., Finlay, D. K., & Gardiner, C. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501783 · Cited by 326
Self-citationMatsuda, M., Korn, B. S., Hammer, R. E., Moon, Y.-A., Komuro, R., Horton, J. D., Goldstein, J. L., Brown, M. S., & Shimomura, I. (2001) · Genes & Development · doi:10.1101/gad.891301 · Cited by 303
Connecting mTORC1 signaling to SREBP-1 activation
Bakan, I., & Laplante, M. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328352dd03 · Cited by 291
Masood, A., Stark, K. D., & Salem, N. (2005) · Journal of Lipid Research · doi:10.1194/jlr.d500022-jlr200 · Cited by 284
IsoCor: correcting MS data in isotope labeling experiments
Millard, P., Létisse, F., Sokol, S., & Portais, J. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts127 · Cited by 278
Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation
Cui, G., Qin, X., Wu, L., Zhang, Y., Sheng, X., Yu, Q., Sheng, H., Xi, B., Zhang, J. Z., & Zang, Y. Q. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42974 · Cited by 276
25-Hydroxycholesterol acts as an amplifier of inflammatory signaling
Gold, E. S., Diercks, A. H., Podolsky, I., Podyminogin, R. L., Askovich, P. S., Treuting, P. M., & Aderem, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404271111 · Cited by 250
Dettmer, K., Nürnberger, N., Kaspar, H., Gruber, M. A., Almstetter, M. F., & Oefner, P. J. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-4425-x · Cited by 243
Self-citationAre Natural Killer Cells Protecting the Metabolically Healthy Obese Patient?
Lynch, L., O’Connell, J., Kwaśnik, A., Cawood, T., O’Farrelly, C., & O'Shea, D. B. (2009) · Obesity · doi:10.1038/oby.2008.565 · Cited by 234
Self-citationHameyer, D., Loonstra, A., Eshkind, L. G., Schmitt, S., Antunes, C., Groen, A., Bindels, E. M., Jonkers, J., Krimpenfort, P., Meuwissen, R. L. J., et al. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00019.2007 · Cited by 200
van der Goot, A. T., Zhu, W., Vázquez‐Manrique, R. P., Seinstra, R. I., Dettmer, K., Michels, H., Farina, F., Krijnen, J., Melki, R., Buijsman, R. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203083109 · Cited by 199
Self-citationO'Shea, D. B., Cawood, T., O’Farrelly, C., & Lynch, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008660 · Cited by 173
Self-citationHawkins, J. L., Robbins, M. D. H., Warren, L. C., Xia, D., Petras, S. F., Valentine, J. J., Varghese, A. H., Wang, I.-K., Subashi, T. A., Shelly, L. D., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139626 · Cited by 145
Sato, R., Okamoto, A., Inoue, J., Miyamoto, W., Sakai, Y., Emoto, N., Shimano, H., & Maeda, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12497 · Cited by 142
Altered NK cell function in obese healthy humans
Laue, T., Wrann, C. D., Hoffmann-Castendiek, B., Pietsch, D., Hübner, L., & Kielstein, H. (2015) · BMC Obesity · doi:10.1186/s40608-014-0033-1 · Cited by 138
The mitochondrial citrate carrier: Metabolic role and regulation of its activity and expression
Gnoni, G. V., Priore, P., Geelen, M. J. H., & Siculella, L. (2009) · IUBMB Life · doi:10.1002/iub.249 · Cited by 111
Metabolic regulation of immune responses: therapeutic opportunities
Aßmann, N., & Finlay, D. K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83005 · Cited by 97
Self-citationIdentification of the Citrate-binding Site of Human ATP-Citrate Lyase Using X-ray Crystallography
Sun, T., Hayakawa, K., Bateman, K., & Fraser, M. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078667 · Cited by 96
Sun, Y., Wang, Q., Yang, G., Lin, C., Zhang, Y., & Yang, P. (2016) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2016.1201721 · Cited by 95
Histone hyperacetylated domains across the Ifng gene region in natural killer cells and T cells
Chang, S., & Aune, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502129102 · Cited by 94
Eibinger, G., Fauler, G., Bernhart, E. M., Frank, S., Hammer, A., Wintersperger, A., Eder, H. G., Heinemann, Á., Mischel, P. S., Malle, E., et al. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.025 · Cited by 76
Fernández-Sánchez, A., Raneros, A. B., Palao, R. C., Sanz, A. B., Ortíz, A., Ortega, F., Suárez-Álvarez, B., & López‐Larrea, C. (2012) · Epigenetics · doi:10.4161/epi.23115 · Cited by 66
Infantino, V., Iacobazzi, V., Santis, F. D., Mastrapasqua, M., & Palmieri, F. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.114 · Cited by 65
Plasma oxysterols and tocopherol in patients with diabetes mellitus and hyperlipidemia
Murakami, H., Tamasawa, N., Matsui, J., Yasujima, M., & Suda, T. (2000) · Lipids · doi:10.1007/s11745-000-0530-1 · Cited by 56
Moon, Y.-A., Lee, J.-J., Park, S. W., Ahn, Y., & Kim, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001066200 · Cited by 55
IκBζ is essential for natural killer cell activation in response to IL-12 and IL-18
Miyake, T., Satoh, T., Kato, H., Matsushita, K., Kumagai, Y., Vandenbon, A., Tani, T., Muta, T., Akira, S., & Takeuchi, O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012977107 · Cited by 52
NK cell function and receptor diversity in the context of HCV infection
Gardiner, C. M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01061 · Cited by 33
Self-citationAssessment of ionic liquid stationary phases for the GC analysis of fatty acid methyl esters
Dettmer, K. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7919-0 · Cited by 28
Self-citationSubverting sterols: rerouting an oxysterol-signaling pathway to promote tumor growth
York, A. G., & Bensinger, S. J. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20131335 · Cited by 27
Bertolotti, M., Puppo, M. D., Corna, F., Anzivino, C., Gabbi, C., Baldelli, E., Carulli, L., Loria, P., Kienle, M. G., & Carulli, N. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.02.009 · Cited by 19
Cited by
Sorted by citations
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877
Natural killer cells in cancer biology and therapy
Wu, S.-Y., Fu, T., Jiang, Y.-Z., & Shao, Z.-M. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01238-x · Cited by 863
Lipid metabolism reprogramming and its potential targets in cancer
Cheng, C., Geng, F., Cheng, X., & Guo, D. (2018) · 癌症:英文版 · doi:10.1186/s40880-018-0301-4 · Cited by 880
Lipid metabolism in cancer: New perspectives and emerging mechanisms
Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V., & Fendt, S. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.013 · Cited by 793
Redox regulation of the immune response
Morris, G., Gevezova, M., Sarafian, V. S., & Maes, M. H. J. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00902-0 · Cited by 628
Metadata
- Authors
- Assmann, N., O'Brien, K. L., Donnelly, R. P., Dyck, L., Zaiatz-Bittencourt, V., Loftus, R. M., Heinrich, P., Oefner, P. J., Lynch, L., Gardiner, C. M., Dettmer, K., & Finlay, D. K.
- Affiliations
- Trinity College Dublin (IE)
- University of Regensburg (DE)
- Corresponding author
- Finlay, David K
- ORCID
- Venue
- Nature Immunology
- Published
- 2017-09-18
- Volume
- 18
- Issue
- 11
- Pages
- 1197-1206
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2755907400
- Cited by
- 375
- References
- 57
- Citations by year
- 2026: 35 · 2025: 54 · 2024: 37 · 2023: 44 · 2022: 53 · 2021: 57 · 2020: 45 · 2019: 25 · 2018: 21 · 2017: 4
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- natural killer cells, SREBP, glucose metabolism, metabolic reprogramming, glycolysis, oxidative phosphorylation, interferon-gamma, NK cell cytotoxicity, cytokine activation, antitumor immunity, viral infection
- MeSH terms
- Animals, Flow Cytometry, Glucose, Glycolysis, Humans, Killer Cells, Natural, Lipids, Oxidative Phosphorylation, Immunoblotting, T-Lymphocyte Subsets, Cytokines, Cell Proliferation, Sterol Regulatory Element Binding Protein 1, Sterol Regulatory Element Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review